Key result
Subcutaneous implantable cardioverter-defibrillators effectively prevent sudden cardiac death with minimal complications compared to transvenous devices due to their extrathoracic placement.
Why the study?
As a newer alternative to transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter-defibrillators require in-depth assessment to clearly understand their effects and complications.
Does the subcutaneous implantable cardioverter-defibrillator (S-ICD) effectively prevent sudden cardiac death and reduce vascular complications compared to transvenous ICDs?
Does the subcutaneous implantable cardioverter-defibrillator (S-ICD) effectively prevent sudden cardiac death and reduce vascular complications compared to transvenous ICDs?
S-ICD is an effective and safe extrathoracic alternative to transvenous ICDs for preventing sudden cardiac death, particularly beneficial as it avoids vascular complications.
May support S-ICD consideration to avoid vascular complications; leaves open need for randomized trials.
An implantable cardioverter-defibrillator (ICD) is one of those devices that is a big boom for the prevention of sudden deaths due to heart failure. This particular device has been in use for just a couple of years, but its impact in the domain has brought about a considerable change in the way a specific issue of the cardiovascular system is tackled. Although subcutaneous or hypodermic implantable cardioverter-defibrillator (S-ICD) is considered to be a better alternative as far as transvenous implantable cardioverter-defibrillator (TV-ICD) is concerned, the former, being a newer introduction in the market, needs to be assessed in depth to clearly understand its effects and complications. Various types of research have been conducted on the efficacy of this device, and in most of the studies, the supremacy of this device is clearly evident when compared with other devices that are used for the same purpose. Better innovations in subcutaneous or hypodermic implantable cardioverter-defibrillators would enable them to be manufactured in a more efficient and cost-effective way so that a huge lot of people are benefited from this device. This review article is a whole peep into the various studies done in this domain, thereby providing adequate scientific insights about subcutaneous or hypodermic implantable cardioverter-defibrillators in a very simple and comprehensive manner.
No takes yet. Share an insight, caveat, or question.
Pagore et al. (2022) conducted a review in Sudden cardiac death. Subcutaneous implantable cardioverter-defibrillator (S-ICD) vs. Transvenous implantable cardioverter-defibrillator (TV-ICD) was evaluated. Subcutaneous implantable cardioverter-defibrillators effectively prevent sudden cardiac death with minimal complications compared to transvenous devices due to their extrathoracic placement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Cureus